Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in AfricaScience (American Association for the Advancement of Science), 2021-10, Vol.374 (6566), p.423-431 [Peer Reviewed Journal]Attribution ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abj4336 ;PMID: 34672751Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
A pooled testing strategy for identifying SARS-CoV-2 at low prevalenceNature (London), 2021-01, Vol.589 (7841), p.276-280 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jan 14, 2021 ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2885-5 ;PMID: 33086375Full text available |
|
3 |
Material Type: Article
|
COVID-19 transmission—up in the airThe Lancet Respiratory Medicine, 2020-12 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/S2213-2600(20)30514-2Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Pathological sequelae of long-haul COVIDNature immunology, 2022-02, Vol.23 (2), p.194-202 [Peer Reviewed Journal]2022. Springer Nature America, Inc. ;Springer Nature America, Inc. 2022. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01104-y ;PMID: 35105985Full text available |
|
5 |
Material Type: Article
|
UniProt: the universal protein knowledgebase in 2021Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D480-D489 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2021 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa1100 ;PMID: 33237286Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
PubChem in 2021: new data content and improved web interfacesNucleic Acids Research, 2021-01, Vol.49 (D1), p.D1388-D1395 [Peer Reviewed Journal]Published by Oxford University Press on behalf of Nucleic Acids Research 2020. 2021 ;Published by Oxford University Press on behalf of Nucleic Acids Research 2020. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa971 ;PMID: 33151290Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical infectious diseases, 2020-11, Vol.71 (16), p.2027-2034 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa344 ;PMID: 32221519Full text available |
|
8 |
Material Type: Article
|
Milder disease with Omicron: is it the virus or the pre-existing immunity?Nature reviews. Immunology, 2022-02, Vol.22 (2), p.69-71 [Peer Reviewed Journal]Springer Nature Limited 2022. ;Springer Nature Limited 2022 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-022-00678-4 ;PMID: 35046570Full text available |
|
9 |
Material Type: Article
|
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunityCell, 2021-04, Vol.184 (9), p.2372-2383.e9 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.013 ;PMID: 33743213Full text available |
|
10 |
Material Type: Article
|
Ensembl 2021Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D884-D891 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2021 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa942 ;PMID: 33137190Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Viral targets for vaccines against COVID-19Nature reviews. Immunology, 2021-02, Vol.21 (2), p.73-82 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00480-0 ;PMID: 33340022Full text available |
|
12 |
Material Type: Article
|
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsCell, 2023-01, Vol.186 (2), p.279-286.e8 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.12.018 ;PMID: 36580913Full text available |
|
13 |
Material Type: Article
|
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Cell, 2021-04, Vol.184 (9), p.2332-2347.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.028 ;PMID: 33761326Full text available |
|
14 |
Material Type: Article
|
Clinical and Laboratory Predictors of In-hospital Mortality in Patients With Coronavirus Disease-2019: A Cohort Study in Wuhan, ChinaClinical infectious diseases, 2020-11, Vol.71 (16), p.2079-2088 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com . 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa538 ;PMID: 32361723Full text available |
|
15 |
Material Type: Article
|
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational studyBMJ (Online), 2022-03, Vol.376, p.e069761-e069761 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-069761 ;PMID: 35264324Full text available |
|
16 |
Material Type: Article
|
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patientsThe Journal of experimental medicine, 2021-03, Vol.218 (3) [Peer Reviewed Journal]2020 Rodrigues et al. ;2020 Rodrigues et al. 2020 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/JEM.20201707 ;PMID: 33231615Full text available |
|
17 |
Material Type: Article
|
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine ImplicationsNew England Journal of Medicine, 2021-05, Vol.384 (19), p.1866-1868 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2100362 ;PMID: 33761203Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort studyBMJ (Online), 2021-03, Vol.372, p.n579-n579 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n579 ;PMID: 33687922Full text available |
|
19 |
Material Type: Article
|
A commentary on 'BF.7 Omicron subvariant (BA.5.2.1.7) posing fears of a rise in COVID-19 cases again: a critical appraisal and salient counteracting strategies'International journal of surgery (London, England), 2024-01, Vol.110 (1), p.582-583 [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2024 ;ISSN: 1743-9159 ;ISSN: 1743-9191 ;EISSN: 1743-9159 ;DOI: 10.1097/JS9.0000000000000766 ;PMID: 37738011Full text available |
|
20 |
Material Type: Article
|
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantNew England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274Digital Resources/Online E-Resources |